07:46 AM EDT, 08/13/2024 (MT Newswires) -- Syros Pharmaceuticals ( SYRS ) shares slumped 64% pre-bell Tuesday after the company said it will stop enrolling new patients in its phase 2 trial of a treatment candidate for acute myeloid leukemia.

Kearny Financial ( KRNY ) shares dropped 19% following a muted session.

Pono Capital Two ( PTWO ) shares were down 13%, reversing from Monday's gains.

PS International Group ( PSIG ) shares fell 11%, paring Monday's rally.

Price: 1.83, Change: -3.18, Percent Change: -63.47